Holen Sie sich die Stockscreener-App
0.3991
5.00%
-0.021
Handel nachbörslich:
.39
-0.0091
-2.28%
Schlusskurs vom Vortag:
$0.4201
Offen:
$0.411
24-Stunden-Volumen:
547.97K
Relative Volume:
0.14
Marktkapitalisierung:
$11.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.29M
KGV:
-8.714
EPS:
-0.0458
Netto-Cashflow:
$-9.72M
1W Leistung:
-13.22%
1M Leistung:
+48.92%
6M Leistung:
-94.48%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.38
$0.4278
1-Wochen-Bereich:
$0.38
$0.535
52-Wochen-Spanne:
$0.262
$9.1796
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Firmenname
Curanex Pharmaceuticals Inc
Sektor
Branche
Telefon
718-673-6078
Adresse
2 JERICHO PLAZA,, JERICHO
Compare CURX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
0.3991 | 11.91M | 0 | -1.29M | -9.72M | -0.0458 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Curanex Pharmaceuticals Inc Aktie (CURX) Neueste Nachrichten
Curanex Forms World Class Scientific Advisory Board - The Manila Times
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
CURX Should I Buy - Intellectia AI
Market Movers | Winners: IXHL, ALBT, RXT | Losers: THRY, EOSE, ERII - Trefis
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Thursday's session: most active stocks - ChartMill
Unusual volume stocks are being observed in Thursday's session. - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Curanex Pharmaceuticals Stock Soars 56.32% After Key IND Milestone - Intellectia AI
24,000,000 Common Stock of Curanex Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 26-FEB-2026. - marketscreener.com
Curanex Pharmaceuticals IncCommon Stock (Nasdaq:CURX) Stock Quote - The Chronicle-Journal
Top movers in Wednesday's after hours session - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Curanex completes GMP pilot batch for ulcerative colitis drug - Investing.com
Curanex Completes GMP Pilot For Phyto-N, Targets IND Submission In Ulcerative Colitis - Nasdaq
Curanex provides operational update on key regulatory milestones - marketscreener.com
Curanex completes GMP pilot batch for ulcerative colitis drug By Investing.com - Investing.com South Africa
New plant-based ulcerative colitis drug targets FDA IND filing in 2026 - Stock Titan
What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours - Sahm
Curanex Provides Operational Update on Key Regulatory Milestones - Bitget
Comparing Curanex Pharmaceuticals (CURX) & The Competition - Defense World
Curanex Pharmaceuticals (CURX) versus Its Peers Financial Survey - Defense World
Financial Contrast: Curanex Pharmaceuticals (CURX) & Its Peers - Defense World
Curanex Pharmaceuticals appoints new chief financial officer - MSN
Contrasting Curanex Pharmaceuticals (CURX) and The Competition - Defense World
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation By Investing.com - Investing.com Nigeria
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation - Investing.com
Curanex Pharmaceuticals (CURX) Competitors and Alternatives 2026 - MarketBeat
Curanex Pharmaceuticals Appoints New Chief Financial Officer - TipRanks
Curanex Pharmaceuticals Announces CFO Transition - TradingView — Track All Markets
Curanex Pharmaceuticals Inc Announces Executive Changes - marketscreener.com
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Curanex Pharmaceuticals Inc(NasdaqCM: CURX) added to S&P TMI Index - MarketScreener
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Weekly Research Analysts’ Ratings Updates for Curanex Pharmaceuticals (CURX) - Defense World
Curanex Pharmaceuticals Inc (CURX) is looking forward to a strong quarter - setenews.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Get insights into the top gainers and losers of Wednesday's pre-market session. - Chartmill
Finanzdaten der Curanex Pharmaceuticals Inc-Aktie (CURX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):